Authors:
CABALLERO F
PELEGRI C
CASTELL M
FRANCH A
CASTELLOTE C
Citation: F. Caballero et al., KINETICS OF W3 25 ANTI-RAT CD4 MONOCLONAL-ANTIBODY STUDIES ON OPTIMALDOSES AND TIME-RELATED EFFECTS/, Immunopharmacology, 39(2), 1998, pp. 83-91
Authors:
PELEGRI C
MORANTE MP
CASTELLOTE C
FRANCH A
CASTELL M
Citation: C. Pelegri et al., TREATMENT WITH AN ANTI-CD4 MONOCLONAL-ANTIBODY STRONGLY AMELIORATES ESTABLISHED RAT ADJUVANT ARTHRITIS, Clinical and experimental immunology, 103(2), 1996, pp. 273-278
Authors:
PELEGRI C
FRANCH A
CASTELLOTE C
CASTELL M
Citation: C. Pelegri et al., IMMUNOHISTOCHEMICAL CHANGES IN SYNOVIAL TISSUE DURING THE COURSE OF ADJUVANT ARTHRITIS, Journal of rheumatology, 22(1), 1995, pp. 124-132
Authors:
PELEGRI C
MORANTE MP
CASTELLOTE C
CASTELL M
FRANCH A
Citation: C. Pelegri et al., ADMINISTRATION OF A NONDEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (W3 25)PREVENTS ADJUVANT ARTHRITIS, EVEN UPON RECHALLENGE - PARALLEL ADMINISTRATION OF A DEPLETING ANTI-CD8 MONOCLONAL-ANTIBODY (OX8) DOES NOT MODIFY THE EFFECT OF W3/25/, Cellular immunology, 165(2), 1995, pp. 177-182
Citation: A. Franch et al., ANTI-TYPE-I COLLAGEN ANTIBODIES IN ADVANCED PHASES OF ADJUVANT ARTHRITIS, Pathology research and practice, 190(2), 1994, pp. 155-158
Citation: A. Franch et al., EFFECT OF ACETYLSALICYLIC-ACID AND DEXAMETHASONE ON ANTIBODY-PRODUCTION IN ADJUVANT ARTHRITIS, Rheumatology international, 14(1), 1994, pp. 27-31
Authors:
FRANCH A
CASSANY S
CASTELLOTE C
CASTELL M
Citation: A. Franch et al., TIME-COURSE OF ANTIBODIES AGAINST IGG AND TYPE-II COLLAGEN IN ADJUVANT ARTHRITIS - ROLE OF MYCOBACTERIA ADMINISTRATION IN ANTIBODY-PRODUCTION, Immunobiology, 190(1-2), 1994, pp. 93-104
Authors:
FRANCH A
CASTELLOTE C
PELEGRI C
TOLOSA E
CASTELL M
Citation: A. Franch et al., BLOOD-B, BLOOD-T, BLOOD-CD4-CD8+ LYMPHOCYTES IN FEMALE WISTAR RATS( AND BLOOD), Annals of hematology, 67(3), 1993, pp. 115-118